Publications by: W. Laupu

Also publishes as (Wendy Laupu, Wendy Kay Laupu)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Number of items: 8.

Laupu, W. (2016) Interpreting outcomes from the supplementation of mangosteen rind powder capsules in schizophrenia and schizoaffective disorders. British Journal Of Medical and Health Research, 3 (9). pp. 15-25.

Laupu, W. (2016) Goitre studies revisited, as a marker for schizophrenia, link diets with inadequate seafood, seaweed and protein to schizophrenia. British Journal Of Medical and Health Research, 3 (6). pp. 35-49.

Laupu, Wendy (2016) Mangosteen Extract's Potential to Treat Schizophrenia: a randomised controlled trial. Lambert Academic Publishing.

Laupu, Wendy Kay (2014) The efficacy of Garcinia mangostana L. (mangosteen) pericarp as an adjunctive to second-generation antipsychotics for the treatment of schizophrenia: a double blind, randomised, placebo-controlled trial. PhD thesis, James Cook University.

Laupu, W., and Brimacombe, J. (2007) The effect of high concentration potassium permanganate on protein contamination from metallic and synthetic rubber airway equipment. Anaesthesia, 62 (8). pp. 824-826.

Laupu, W., Brimacombe, J., Richards, E., and Keller, C. (2006) High concentration potassium permanganate eliminates protein and particle contamination of the reusable Classic™ laryngeal mask airway. Anaesthesia, 61 (6). pp. 524-527.

Richards, E., Brimacombe, J., Laupu, W., and Keller, C. (2006) Protein cross-contamination during batch cleaning and autoclaving of the ProSeal laryngeal mask airway. Anaesthesia, 61 (5). pp. 431-433.

Laupu, Wendy, and Brimacombe, Joseph (2004) Potassium permanganate reduces protein contamination of reusable laryngeal mask airways. Anesthesia & Analgesia, 99 (6). pp. 614-616.

This list was generated on Tue Mar 5 15:10:59 2024 AEST.